Abstract Chest-regional recurrence and metastasis are the main modes of treatment failure after surgery for patients with esophageal cancer. As one of the primary approaches for local therapy, radiotherapy has a satisfactory efficacy in the reduction of postoperative chest-regional recurrence in patients with esophageal cancer. Right now, the value of postoperative adjuvant therapy for patients with positive lymph nodes has been widely recognized by clinicians. Postoperative adjuvant chemoradiotherapy has become a standard treatment mode. However, there is no consensus on whether adjuvant radiotherapy should be performed in patients with negative lymph nodes. To determine whether patients with stage pN0 esophageal cancer should receive postoperative adjuvant therapy, this paper reviews the current research advances in possible evidence for the necessity of postoperative adjuvant radiotherapy for patients with stage pN0 esophageal cancer, current related reports, and the effects of different surgical methods on treatment outcomes of postoperative adjuvant therapy.
Shen wenbin,Zhu Shuchai. Research advances in postoperative adjuvant radiotherapy for stage pN0 esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(1): 111-115.
Shen wenbin,Zhu Shuchai. Research advances in postoperative adjuvant radiotherapy for stage pN0 esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(1): 111-115.
[1] 肖泽芬,杨宗贻,王绿化,等.食管癌术后淋巴结转移对生存率的影响和放疗的意义[J].中华肿瘤杂志,2004,26(2):112-115.DOI:10.3760/j.issn:0253-3766.2004.02.016. Xiao ZF,Yang ZY,Wang LH,et al. Influence of the number 0f lymph node metastasis on survival andsignificance of postoperative radiotherapy for esophageal carcinoma[J].Chin J Oncol,2004,26(2):112-115.DOI:10.3760/j.issn:0253-3766.2004.02.016. [2] 陈俊强,潘建基,李建成,等.淋巴结阳性胸段食管鳞癌术后放化疗临床研究[J].中华放射肿瘤学杂志,2011,20(4):287-290.DOI:10.3760/cma.j.issn.1004-4221.2011.04.008. Chen JQ,Pang JJ,Li JCH,et al. Clinical study of postoperative chemoradiotherapy of thoracic esophageal squamous cell carcinoma with positive lymph nodes[J].Chin J Radio Oncol, 2011,20(4):287-290.DOI:10.3760/cma.j.issn.1004-4221.2011.04.008. [3] 林宇,陈俊强,李建成,等.淋巴结阳性胸段食管鳞癌术后放化疗的价值[J].中华肿瘤杂志,2014,36(2):151-154.DOI:10.3760/cma.j.issn.0253-3766.2014.02.018. Lin Y,Chen JQ,Li JCH,et al. Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis[J].Chin J Oncol, 2014,36(2):151-154. [4] Chen JQ,Pan JJ,Liu J,et al. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma[J].Int J Radiat Oncol Biol Phys,2013,86(4):671-677.DOI:10.1016/j.ijrobp.2013.03.026. [5] Wang ZW,Luan ZP,Zhang W,et al. Postoperative chemoradiotherapy improves survival in esophageal squamous cell cancer with extracapsular lymph node extension[J].Neoplasma,2014,61(6):732-738.DOI:10.4149/neo_2014_089. [6] Bedard EL,Inculet RI,Malthaner RA,et al. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma[J].Cancer,2001,91(12):2423-2430.DOI:10.1002/1097-0142(20010615)91:12<2423::AID-CNCR1277>3.3.CO;2-T. [7] Rice TW,Rusch VW,Apperson-Hansen C,et al. Worldwide esophageal cancer collaboration[J].Dis Esophagus,2009,22(1):1-8.DOI:10.1111/j.1442-2050.2008.00901.x. [8] Ishwaran H,Blackstone EH,Apperson-Hansen C,et al. A novel approach to cancer staging:application to esophageal cancer[J].Biostatistics,2009,10(4):603-620.DOI:10.1093/biostatistics/kxp016. [9] Thompson SK,Ruszkiewicz AR,Jamieson GG,et al. Improving the accuracy of TNM staging in esophageal cancer:a pathological review of resected specimens[J].Ann Surg Oncol,2008,15(12):3447-4358.DOI:10.1245/s10434-008-0155-0. [10] Chen JQ,Zhu J,Pan JJ,et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus[J].Ann Thorac Surg,2010,90(2):435-442.DOI:10.1016/j.athoracsur.2010.04.002. [11] Smit JK,Pultrum BB,van Dullemen HM,et al. Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy[J].Am J Surg,2010,200(4):446-453.DOI:10.1016/j.amjsurg.2009.12.006. [12] 王洲,刘相燕,刘凡英,等.N0期食管癌术后早期复发与淋巴结微转移的相关性研究[J].中华外科杂志,2004,42(2):68-71.DOI:10.3760/j:issn:0529-5815.2004.02.002. Wang Z,Liu XY,Liu YF,et al. A study of correlation between early postoperative relapse with lymph node micrometastasis in patients with N0 esophageal cancer[J].Chin J surg,2004,42(2):68-71.DOI:10.3760/j:issn:0529-5815.2004.02.002. [13] 李林,柳硕岩,朱坤寿,等.早期食管癌淋巴结转移规律与预后分析[J].中华肿瘤杂志,2009,31(3):226-229.DOI:10.3760/cma.j.issn.0253-3766.2009.03.018. Li L,Liu SY,Zhu KS,et al. Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens[J].Chin J Oncol, 2009,31(3):226-229.DOI:10.3760/cma.j.issn.0253-3766.2009.03.018. [14] Kasai M,Mori S,Watanabe T.Follow-up results after resection of thoracic esophageal carcinoma[J].World J Surg,1978,2(4):543-549.DOI:10.1007/BF01563699. [15] 乔红梅,丁富强,宋丽萍.食管癌根治术后放疗的疗效分析[J].现代肿瘤医学,2010,18(10):1982-1984.DOI:10.3969/j.issn.1672-4992.2010.10.36. Qiao HM,Ding FQ,Song LP.Effect of postoperative radiotherapy after radical resection for esophageal carcinoma[J].J Modern Oncol, 2010,18(10):1982-1984.DOI:10.3969/j.issn.1672-4992.2010.10.36. [16] 李维贵,张德洲,马俊杰,等.食管癌根治术后放疗临床疗效分析[J].中华放射肿瘤学杂志,2004,13(4):342-343.DOI:10.3760/j.issn:1004-4221.2004.04.030. Li WG,Zhang DZ,Ma JJ,et al. Clinical analysis of radiotherapy after radical resection of esophageal cancer[J].Chin J Radio Oncol, 2004,13(4):342-343.DOI:10.3760/j.issn:1004-4221.2004.04.030. [17] 朱海文,陈国雄,王迎选,等.食管癌术后放疗[J].中华放射肿瘤学杂志,1998,7(1):46-48. Zhu HW,Chen GX,Wang YX,et al. Radiotherapy after radical resection of esophageal cancer Chin J Radio Oncol, 2004,13(4):342-343.DOI:10.3760/j.issn:1004-4221.2004.04.030. [18] Teninere P,Hay JM,Fingerhut A,et al. Postoperation radiation therapy dose not increase survival after curative resection for squamous as shown by a multicenter controlled trail[J].Surg Gynecol Obstet,1991,173(2):123-129. [19] Xiao ZF,Yang ZY,Liang J,et al. Value of radiotherapy after radical surgery for esophageal carcinoma:a report of 495 patients[J].Ann Thorac Surg,2003,75(2):331-336.DOI:10.1016/S0003-4975(02)04401-6. [20] 陈俊强,潘建基,陈明强,等.N0期食管鳞癌术后预防性放疗价值探讨[J].中华放射肿瘤学杂志,2009,18(4):261-264.DOI:10.3760/cma.j.issn.1004-4221.2009.04.261. Chen JQ,Pang JJ,Chen MQ,et al. Postoperative prophylactic radiotherapy for N0 esophageal squamous cell carcinoma[J].Chin J Radio Oncol, 2009,18(4):261-264.DOI:10.3760/cma.j.issn.1004-4221.2009.04.261. [21] 孔祥泉,陈俊强,朱坤寿,等.N0期食管鳞癌三野根治术后放疗价值的临床研究[J].实用临床医药杂志,2009,13(11):12-15.DOI:10.3969/j.issn.1672-2353.2009.21.004. Kong XQ,Chen JQ,Zhu KS,et al. A Clinical study on the Value of postoperative radiotherapy after three—field lymphadenectomy in N0 esophageal squamous cell carcinoma[J].J Clinic Medic Practice, 2009,13(11):12-15.DOI:10.3969/j.issn.1672-2353.2009.21.004. [22] 陆进成,钱普东,查文武,等.食管癌根治术后预防性放疗随机研究的Meta分析[J].循证医学,2005,5(3):166-169.DOI:10.3969/j.issn.1671-5144.2005.03.010. Lu JC,Qian PD,Cha WW,et al. Meta analysis of randomized study of prophylactic radiotherapy after radical surgery for esophageal cancer[J].Evidence-based medicine,2005,5(3):166-169.DOI:10.3969/j.issn.1671-5144.2005.03.010. [23] Martin JT,Worni M,Zwischenberger JB,et al. The role of radiation therapy in resected T2 N0 esophageal cancer:a population-based analysis[J].Ann Thorac Surg,2013,95(2):453-458.DOI:10.1016/j.athoracsur.2012.08.049. [24] Worni M,Martin J,Gloor B,et al. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008[J].J Am Coll Surg,2012,215(5):643-651.DOI:10.1016/j.jamcollsurg.2012.07.006. [25] Schreiber D,Rineer J,Vongtama D,et al. Impact of postoperative radiation after esophagectomy for esophageal cancer[J].J Thorac Oncol,2010,5(2):244-250.DOI:10.1097/JTO.0b013e3181c5e34f. [26] Shridhar R,Weber J,Hoffe SE,et al. Adjuvant radiation therapy and lymphadenectomy in esophageal cancer:a seer database analysis[J].J Gastrointest Surg,2013,17(8):1339-1345.DOI:10.1007/s11605-013-2192-7. [27] 章文成,王奇峰,肖泽芬,等.Ⅱ和Ⅲ期胸段食管癌术后预防性三维放疗疗效分析[J].中华放射肿瘤学杂志,2012,21(2):136-139.DOI:10.3760/cma.j.issn.1004-4221.2012.02.012. Zhang WC,Wang QF,Xiao ZF,et al. A efficacy analysis of intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for resected thoracic esophageal squamons cell carcinoma[J].Chin J Radio Oncol, 2012,21(2):136-139.DOI:10.3760/cma.j.issn.1004-4221.2012.02.012. [28] 刘晓,章文成,于舒飞,等.T2-3N0M0期食管癌R0术后失败模式分析-术后放疗潜在价值与意义[J].中华放射肿瘤学杂志,2015,24(1):19-24.DOI:10.3760/cma.j.issn.1004-4221.2015.01.006. Liu X,Zhang WC,Yu SF,et al. The potential value and significance of postoperative radiotherapy for patients with stage T2-3N0M0 esophageal carcinoma after R0 failure mode analysis[J].Chin J Radio Oncol, 2015,24(1):19-24.DOI:10.3760/cma.j.issn.1004-4221.2015.01.006. [29] 杨劲松,刘晓,肖泽芬,等.pT2-3N0M0期食管癌根治术后3DRT前瞻性Ⅱ期临床研究[J].中华放射肿瘤学杂志,2015,24(1):29-32.DOI:10.3760/cma.j.issn.1004-4221.2015.01.008. Yang JS,Liu X,Xiao ZF,et al. Prospective phase Ⅱ study of three-dimensional radiotherapy after radical surgery for pT2N0M0 esophageal cancer[J].Chin J Radio Oncol, 2015,24(1):29-32.DOI:10.3760/cma.j.issn.1004-4221.2015.01.008. [30] 杨劲松,章文成,肖泽芬,等.术后辅助3DRT改善pT3N0M0期食管癌患者长期生存[J].中华放射肿瘤学杂志,2015,24(2):101-105.DOI:10.3760/cma.j.issn.1004-4221.2015.02.001. Yang JS,Zhang WC,Xiao ZF,et al. Postoperative adjuvant three-dimensional conformal radiotherapy improves long-term survival in patients with pathological T弼料oMo esophageal cancer[J].Chin J Radio Oncol, 2015,24(2):101-105.DOI:10.3760/cma.j.issn.1004-4221.2015.02.001. [31] 李成林,王雅棣,孙国贵,等.食管癌二野淋巴结清扫术后复发规律探讨[J].中华放射肿瘤学杂志,2011,20(2):118-121.DOI:10.3760/cma.j.issn.1004-4221.2011.02.010. Li CL,Wang YD,Sun GG,et al.ecurrence patterns of thorade esophageal cancer after two-field lymph node dissection[J].Chin J Radio Oncol, 2011,20(2):118-121.DOI:10.3760/cma.j.issn.1004-4221.2011.02.010. [32] Li CL,Zhang FL,Wang YD,et al. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer[J].Oncol Lett,2013,5(1):355-359.DOI:10.3892/ol.2012.946. [33] Dresner SM,Griffin SM.Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy[J].Br J Surg,2000,87(10):1426-1433.DOI:10.1046/j.1365-2168.2000.01541.x. [34] Lu LC,Tao H,Zhang YQ,et al. Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma[J].Dis Esophagus,2008,21(6):502-507.DOI:10.1111/j.1442-2050.2007.00797.x. [35] Yu E,Tai P,Younus J,et al. Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients:a prospective experience[J].Curr Oncol,2009,16(4):48-54. [36] Altorki N,Kent M,Ferrara C,et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus[J].Ann Surg,2002,236(2):177-183.DOI:10.1097/00000658-200208000-00005. [37] Luketich JD,Kassis ES,Shriver SP,et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer[J].Ann Thorac Surg,1998,66(5):1715-1718.DOI:10.1016/S0003-4975(98)00944-8. [38] Izbicki JR,Hosch SB,Pichlmeier U,et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer[J].N Engl J Med,1997,337(17):1188-1194.DOI:10.1056/NEJM199710233371702. [39] 朱坤寿,佘志廉,陈俊强,等.胸段食管癌三野根治术及术后预防性放疗的临床意义[J].中华肿瘤防治杂志,2006,13(10):763-765.DOI:10.3969/j.issn.1673-5269.2006.10.012. Zhu KS,Yu ZL,Chen JQ,et al. Clinical significance of postoperative prophylactic radiotherapy in patients with thoracic esophageal cancer and Sanye[J].Chin J Can Preven Treatment,2006,13(10):763-765.DOI:10.3969/j.issn.1673-5269.2006.10.012. [40] Chen JQ,Pan JJ,Zheng XW,et al. Number and location of positive nodes,postoperative radiotherapy,and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma[J].Int J Radiat Oncol Biol Phys,2012,82(1):475-482.DOI:10.1016/j.ijrobp.2010.08.037. [41] Greenstein AJ,Litle VR,Swanson SJ,et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer[J].Cancer,2008,112(6):1239-1246.DOI:10.1002/cncr.23309. [42] Rizk N,Venkatraman E,Park B,et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer:implications for revisions of the American Joint Committee on Cancer Staging system[J].J Thorac Cardiovasc Surg,2006,132(6):1374-1381.DOI:10.1016/j.jtcvs.2006.07.039. [43] Bollschweiler E,Baldus SE,Schrder W,et al. Staging of esophageal carcinoma:length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?[J].J Surg Oncol,2006,94(5):355-363.DOI:10.1002/jso.20569.
2017, Vol. 26 
